BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 38239299)

  • 1. Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment.
    Cheng H; Zheng Y
    PeerJ; 2024; 12():e16825. PubMed ID: 38239299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
    Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
    Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Tumor Metabolic Reprogramming in Tumor Immunity.
    Zhang X; Song W; Gao Y; Zhang Y; Zhao Y; Hao S; Ni T
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
    Li L; Ma SR; Yu ZL
    Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
    Yan L; Tan Y; Chen G; Fan J; Zhang J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy.
    Miao L; Lu C; Zhang B; Li H; Zhao X; Chen H; Liu Y; Cui X
    J Transl Med; 2024 Mar; 22(1):229. PubMed ID: 38433193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
    Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
    Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
    Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
    Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research Progress and New Immunotherapy Strategies of Tumor Microenvironment Metabolism].
    Peng YM; Luo XM; Chen JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):505-509. PubMed ID: 37248575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in Research on Cell Metabolic Interactions in the Tumor Microenvironment].
    Wu P; Yang Z; Li Q; Wang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):482-489. PubMed ID: 38645846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lipid metabolic reprogramming in tumor microenvironment.
    Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
    Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment.
    Wang S; Liu G; Li Y; Pan Y
    Front Immunol; 2022; 13():840029. PubMed ID: 35874739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
    Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
    Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic interplay: tumor macrophages and regulatory T cells.
    Vilbois S; Xu Y; Ho PC
    Trends Cancer; 2024 Mar; 10(3):242-255. PubMed ID: 38135571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity.
    Zhang J; Wei L; Ma X; Wang J; Liang S; Chen K; Wu M; Niu L; Zhang Y
    Acta Biomater; 2023 Aug; 166():470-484. PubMed ID: 37253416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
    Bahrambeigi S; Shafiei-Irannejad V
    Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Regulation of CD8
    Zheng Y; Wang X; Huang M
    Antioxid Redox Signal; 2022 Dec; 37(16-18):1234-1253. PubMed ID: 35345890
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic reprogramming in the tumor microenvironment of liver cancer.
    Lin J; Rao D; Zhang M; Gao Q
    J Hematol Oncol; 2024 Jan; 17(1):6. PubMed ID: 38297372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlocking the potential of T-cell metabolism reprogramming: Advancing single-cell approaches for precision immunotherapy in tumour immunity.
    Huang L; Li H; Zhang C; Chen Q; Liu Z; Zhang J; Luo P; Wei T
    Clin Transl Med; 2024 Mar; 14(3):e1620. PubMed ID: 38468489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.